Skye Bioscience Establishes New Cannabinoid Pharmaceutical Innovation Program
Exclusive sponsored research agreement with endocannabinoid research pioneers SAN DIEGO, CA, Oct. 12, 2021 (GLOBE…
Exclusive sponsored research agreement with endocannabinoid research pioneers SAN DIEGO, CA, Oct. 12, 2021 (GLOBE…
Oslo, 12 October 2021, the Board of Directors of Ultimovacs ASA (the “Company”) has resolved…
Key leadership addition to support operational growth and drive company preparedness towards IPO AVENTURA, Fla.,…
Strong safety data from NORSE THREE registration trial consistent with other trials for ONS-5010 and in…
2021 HALF-YEAR EARNINGS EBITDA up +110% to €42.5mNet cash of €60.4mCOVID accelerating the Group’s longstanding…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Presentation highlights pre-clinical data from Rakovina Therapeutics’ novel kt-3000 series dual PARP-HDAC inhibitors VANCOUVER, British…
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
ZURICH, Switzerland, Oct. 12, 2021 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering a…
Figure 1 In vivo mice survival in experimental CRC liver metastasis model Not for distribution…
WESTMINSTER, Colo., Oct. 12, 2021 (GLOBE NEWSWIRE) — GeneThera, Inc. (OTCMKT: GTHR) announced today that…
Chief Science Officer Dr. Khursheed Anwer to Deliver Virtual Presentation on Celsion’s Ongoing Work with…
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,”…
JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage…
Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada Valuation of approximately 3.5x…
– Lead program, ADAIR, advancing toward completion of patient enrollment and treatment in ongoing SEAL…
– Agreement to accelerate commercialization of Bylvay™ (odevixibat) in Japan, a significant market for PFIC, Alagille…
Record quarterly revenue and instrument placements Company to report third quarter 2021 financial results on…
BASEL, Switzerland, Oct. 12, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused…
Globally Recognized Experts in Gastrointestinal Diseases, Cystic Fibrosis and Virology to Support Company in Advancing…